ZFP36L1
mRNA decay activator protein ZFP36L1
Also known as: Berg36, BRF1, cMG1, ERF1, RNF162B, TIS11B, TISB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q07352
- Gene
- ZFP36L1
- Ensembl
- ENSG00000185650
- Chromosome
- 14
- Canonical length
- 338 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
This gene is a member of the TIS11 family of early response genes, which are induced by various agonists such as the phorbol ester TPA and the polypeptide mitogen EGF. This gene is well conserved across species and has a promoter that contains motifs seen in other early-response genes. The encoded protein contains a distinguishing putative zinc finger domain with a repeating cys-his motif. This putative nuclear transcription factor most likely functions in regulating the response to growth factors. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
338 residues, UniProt reviewed canonical sequence.
>Q07352|ZFP36L1
1 MTTTLVSATI FDLSEVLCKG NKMLNYSAPS AGGCLLDRKA VGTPAGGGFP RRHSVTLPSS
61 KFHQNQLLSS LKGEPAPALS SRDSRFRDRS FSEGGERLLP TQKQPGGGQV NSSRYKTELC
121 RPFEENGACK YGDKCQFAHG IHELRSLTRH PKYKTELCRT FHTIGFCPYG PRCHFIHNAE
181 ERRALAGARD LSADRPRLQH SFSFAGFPSA AATAAATGLL DSPTSITPPP ILSADDLLGS
241 PTLPDGTNNP FAFSSQELAS LFAPSMGLPG GGSPTTFLFR PMSESPHMFD SPPSPQDSLS
301 DQEGYLSSSS SSHSGSDSPT LDNSRRLPIF SRLSISDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZFP36L1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 479 nTPM
Expression across tissuesHPA
Tissue
- skin: 479 nTPM
- vagina: 433 nTPM
- ovary: 423 nTPM
- cervix: 416 nTPM
- blood vessel: 375 nTPM
- endometrium: 365 nTPM
Single-cell type
- ocular epithelial cells: 2,411 nCPM
- prostatic club cells: 2,355 nCPM
- suprabasal keratinocytes: 2,238 nCPM
- epididymal efferent duct absorptive cells: 1,950 nCPM
- epididymal basal cells: 1,662 nCPM
- decidual stromal cells: 1,499 nCPM
Immune cell
- neutrophil: 2,922 nTPM
- naive B-cell: 463 nTPM
- memory B-cell: 267 nTPM
- total PBMC: 258 nTPM
- intermediate monocyte: 245 nTPM
- classical monocyte: 242 nTPM
Brain region
- medulla oblongata: 355 nTPM
- midbrain: 324 nTPM
- hypothalamus: 316 nTPM
- spinal cord: 287 nTPM
- white matter: 281 nTPM
- thalamus: 239 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ZFP36L1.
Disease | ImmuneIEDB
Conditions an epitope on ZFP36L1 was assayed in.
- glioblastoma T cell
- type 1 diabetes mellitus T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.6
- gnomAD pLI
- 0.67
- gnomAD missense Z
- 2.56
- DepMap mean gene effect
- -0.25
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 3'-UTR-mediated mRNA destabilization
- apoptotic process
- cell population proliferation
- cellular response to cAMP
- cellular response to epidermal growth factor stimulus
- cellular response to fibroblast growth factor stimulus
- cellular response to glucocorticoid stimulus
- cellular response to hypoxia
- cellular response to insulin stimulus
- cellular response to peptide hormone stimulus
- cellular response to raffinose
- cellular response to salt stress
- cellular response to transforming growth factor beta stimulus
- cellular response to tumor necrosis factor
- chorio-allantoic fusion
- ERK1 and ERK2 cascade
- heart development
- MAPK cascade
- mesendoderm development
- mRNA processing
- mRNA transport
- multicellular organism growth
- negative regulation of erythrocyte differentiation
- negative regulation of mitotic cell cycle phase transition
- neural tube development
- nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
- nuclear-transcribed mRNA catabolic process, deadenylation-independent decay
- p38MAPK cascade
- phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of fat cell differentiation
- positive regulation of intracellular mRNA localization
- positive regulation of monocyte differentiation
- positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
- proepicardium development
- regulation of B cell differentiation
- regulation of gene expression
- regulation of keratinocyte apoptotic process
- regulation of keratinocyte differentiation
- regulation of keratinocyte proliferation
- regulation of mRNA 3'-end processing
- regulation of mRNA stability
- regulation of myoblast differentiation
- regulation of stem cell proliferation
- regulation of translation
- response to wounding
- T cell differentiation in thymus
- vasculogenesis
Molecular functions
- 14-3-3 protein binding
- DNA binding
- mRNA 3'-UTR AU-rich region binding
- mRNA binding
- RNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZFP36L1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZFP36L1 as an antibody target. Whether an autoantibody or antibody against ZFP36L1 could matter depends on whether native ZFP36L1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZFP36L1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZFP36L1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...